{
 "name": "國璽幹細胞",
 "slug": "tw-6704",
 "aliases": [
  "國璽幹細胞應用技術股份有限公司",
  "GWOXI",
  "6704"
 ],
 "ticker": "6704",
 "industry": "生技醫療業",
 "website": "http://www.gwoxi.com.tw",
 "summary": "國璽幹細胞（6704）是興櫃的生技醫療類股公司，2004 年成立，2023 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "國璽幹細胞應用技術股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "GWOXI",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2023-04-26",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2004-03-26",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "莊明熙",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "邱淳芬",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 1059493160,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "勤業眾信聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "http://www.gwoxi.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：GXNPC1（思益優）",
   "value": "慢性腦中風｜第三期人體臨床試驗獲衛福部原則同意進行｜台灣",
   "unit": "",
   "as_of": "2026-08-13",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01",
   "note": "查詢6704、115年度、全年度、序號1。發言日期2026-08-13 16:48:17；主旨：國璽幹細胞新藥思益優GXNPC1治療慢性腦中風第三期人體臨床試驗獲衛生福利部同意進行。公告文字為原則同意，不等於已收案或上市。既往第二期試驗NCT04088149已完成，並非第三期NCT編號。"
  },
  {
   "claim": "管線：GXCPC1（軟實立）",
   "value": "退化性膝關節炎｜第三期人體臨床試驗獲衛福部原則同意進行｜台灣",
   "unit": "",
   "as_of": "2025-05-12",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01",
   "note": "查詢6704、114年度、全年度、序號1。發言日期2025-05-12 18:47:53；主旨：國璽異體脂肪幹細胞新藥軟實立GXCPC1治療退化性關節炎第三期人體臨床試驗獲衛生福利部同意進行。既往I/II試驗NCT03943576不作為第三期登錄號。"
  },
  {
   "claim": "管線：GXIPC1（怡導速）",
   "value": "第一型糖尿病｜第一期臨床試驗結案報告獲越南衛生部證明書｜越南",
   "unit": "",
   "as_of": "2025-10-21",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01",
   "note": "查詢6704、114年度、全年度、序號1。發言日期2025-10-21 17:13:22；主旨：本公司接獲越南合作夥伴VRISG通知，脂肪來源間質幹細胞(GXIPC1)治療第一型糖尿病完成第一期臨床試驗結案報告，獲越南衛生部證明書(補充113/12/09重訊)。NCT05308836；公告第5(二)項列明該登錄號。完成試驗結案不等於已取得藥品上市許可。"
  }
 ],
 "provided_by": "public_sources",
 "verified_at": "2026-10-22",
 "url": "https://drugnews.com.tw/companies/tw-6704.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}